Premium
KalVista Pharmaceuticals Inc (4XC1)
TG
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| VR Management, LLC | Institution | 6 474 485 | 12,16% | - | 2026-03-31 |
| Suvretta Capital Management, LLC | Institution | 4 768 712 | 8,96% | - | 2026-03-31 |
| Tang Capital Management, LLC | Institution | 4 573 530 | 8,59% | - | 2026-03-31 |
| Averill Master Fund, Ltd. | Institution | 3 971 025 | 7,46% | - | 2024-09-30 |
| Venrock Healthcare Capital Partners EG, L.P. | Institution | 3 883 192 | 7,29% | - | 2026-03-26 |
| BlackRock, Inc. | Institution | 3 795 859 | 7,13% | - | 2026-03-31 |
| Silverarc Capital Management, LLC | Institution | 2 876 407 | 5,40% | - | 2026-03-31 |
| Capital Research and Management Company | Institution | 2 808 583 | 5,28% | - | 2026-03-31 |
| Point72 Associates, LLC | Institution | 2 781 902 | 5,23% | - | 2026-01-05 |
| Glazer Capital, LLC | Institution | 2 581 700 | 4,85% | - | 2026-06-03 |
| Point72 Asset Management, L.P. | Institution | 2 136 940 | 4,01% | - | 2026-03-31 |
| Emerald Advisers, LLC | Institution | 2 069 785 | 3,89% | - | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 1 955 844 | 3,67% | - | 2026-03-31 |
| Millennium Management LLC | Institution | 1 912 146 | 3,59% | - | 2026-03-31 |
| Medical Strategy GmbH | Institution | 1 876 650 | 3,52% | - | 2025-12-31 |
| Vestal Point Capital, LP | Institution | 1 850 000 | 3,47% | - | 2026-03-31 |
| Parkman Healthcare Partners LLC | Institution | 1 835 506 | 3,45% | - | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 1 830 467 | 3,44% | - | 2026-03-31 |
| Frazier Life Sciences Management, LP | Institution | 1 829 303 | 3,44% | - | 2026-05-19 |
| Kynam Capital Management, LP | Institution | 1 820 954 | 3,42% | - | 2026-03-31 |
| Integrated Core Strategies (US) LLC | Institution | 1 546 105 | 2,90% | - | 2026-03-31 |
| Woodline Partners LP | Institution | 1 509 920 | 2,84% | - | 2026-03-31 |
| Octagon Capital Advisors LP | Institution | 1 450 000 | 2,72% | - | 2026-03-31 |
| Frazier Life Sciences Public Fund, L.P. | Institution | 1 249 165 | 2,35% | - | 2026-05-19 |
| Armistice Capital LLC | Institution | 1 236 000 | 2,32% | - | 2026-03-31 |
| Venrock Healthcare Capital Partners III, L.P. | Institution | 1 096 478 | 2,06% | - | 2026-03-26 |
| Elmind Capital, L.P. | Institution | 1 021 300 | 1,92% | - | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 996 235 | 1,87% | - | 2026-03-31 |
| Squadron Capital Management Llc | Institution | 985 100 | 1,85% | - | 2026-03-31 |
| Frazier Life Sciences Public Overage Fund, L.P. | Institution | 946 074 | 1,78% | - | 2025-08-18 |
| Spruce Street Capital LP | Institution | 897 681 | 1,69% | - | 2026-03-31 |
| Freestone Grove Partners LP | Institution | 882 906 | 1,66% | - | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 751 318 | 1,41% | - | 2026-03-31 |
| Great Point Partners, LLC | Institution | 675 000 | 1,27% | - | 2026-03-31 |
| BNY Asset Management | Institution | 584 347 | 1,10% | - | 2026-03-31 |
| Driehaus Capital Management LLC | Institution | 564 039 | 1,06% | - | 2026-03-31 |
| UBS Asset Management AG | Institution | 550 393 | 1,03% | - | 2026-03-31 |
| Barclays PLC | Institution | 536 538 | 1,01% | - | 2026-03-31 |
| Schroder Investment Management Limited | Institution | 506 743 | 0,95% | - | 2026-03-31 |
| Bank of America Corporation | Institution | 491 519 | 0,92% | - | 2026-03-31 |
| Frazier Life Sciences X, L.P. | Institution | 427 983 | 0,80% | - | 2026-05-19 |
| Catalio Capital Management, LP | Institution | 426 551 | 0,80% | - | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
